Last reviewed · How we verify
Mucopolysaccharide Polysulfate Cream and glucocorticoids
Glucocorticoids exert their effects by binding to the glucocorticoid receptor (GR) in the cytoplasm, which then translocates to the nucleus and regulates gene expression.
Glucocorticoids exert their effects by binding to the glucocorticoid receptor (GR) in the cytoplasm, which then translocates to the nucleus and regulates gene expression. Used for Skin allergies, Inflammatory bowel disease.
At a glance
| Generic name | Mucopolysaccharide Polysulfate Cream and glucocorticoids |
|---|---|
| Also known as | Hirudoid® and glucocorticoids |
| Sponsor | Shenzhen Kangzhe Pharmaceutical Co., Ltd. |
| Drug class | Glucocorticoid |
| Target | Glucocorticoid receptor (GR) |
| Modality | Small molecule |
| Therapeutic area | Dermatology, Immunology, Gastroenterology |
| Phase | Phase 2 |
Mechanism of action
Glucocorticoids have anti-inflammatory and immunosuppressive properties, making them useful in treating various conditions such as skin allergies and inflammatory bowel disease.
Approved indications
- Skin allergies
- Inflammatory bowel disease
Common side effects
- Hypertension
- Hyperglycemia
- Osteoporosis
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: